Insider Transactions Reported by 12 Insiders of Gain Therapeutics, Inc.

Symbol
GANX on Nasdaq
Location
Bethesda, MD

There are no Buy or Sell transactions made by insiders since 30 Dec 2024

Gain Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthias Alder Chief Executive Officer, Director $2,278,633 26 Mar 2024
ERIC I. RICHMAN Director $1,262,803 24 Jun 2025
Gene Mack CEO, President, Director $1,186,544 20 Mar 2025
Khalid Islam Director $1,017,567 24 Jun 2025
Charles Evan Ballantyne Chief Financial Officer $711,000 10 Apr 2023
Salvatore Calabrese Chief Financial Officer $362,880 23 Mar 2023
Gianluca Fuggetta Principal Accounting and Financial Officer $293,000 20 Mar 2025
Claude Nicaise Director $87,900 24 Jun 2025
GOLDSTEIN DOV A MD Director $87,900 24 Jun 2025
Gwen A. Melincoff Director $87,900 24 Jun 2025
HASLER HANS PETER Director $87,900 24 Jun 2025
Jeffrey Scott Riley Director $87,900 24 Jun 2025

Recent Insider Transactions by Companies or Individuals for Gain Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.